Quality of diabetes care in India, China, Brazil, Mexico and Russia

Practical Diabetes International

Volumn 26, Issue 5, 2009, Pages 195-200i

  Strock, Ellie S ^a   Mazze, Roger S ^a,b  

^a INTERNATIONAL DIABETES CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Diabetes care; Quality improvement; Staged diabetes management

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAZIL; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE QUALITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MEXICO; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RUSSIAN FEDERATION; TREND STUDY;

EID: 70450207380     PISSN: 13578170     EISSN: 1528252X     Source Type: Journal    
DOI: 10.1002/pdi.1371     Document Type: Article

References (25)

1. Diabetes Atlas, 3rd edn. Brussels: International Diabetes Federation, 2006.
2. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5): 1047-1053.
3. DCCT Study Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329(14): 977-986.
4. UKPDS Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(9131): 837-853.
5. UKPDS Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317(7160): 703-713. (Pubitemid 28414300)
6. DCCT Study Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000; 342(6): 381-389.
7. Nathan DM, Cleary PA, Backlund JY, et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353(25): 2643-2653.
8. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359(15): 1577-1589.
9. Mazze RS, Etzwiler DD, Strock E, et al. Staged diabetes management. Toward an integrated model of diabetes care. Diabetes Care 1994; 17(Suppl 1): 56-66. (Pubitemid 24162005)
10. Mazze RS, Strock ES, Simonson GD, et al. Staged Diabetes Management: A Systematic Approach, 2nd edn. Chichester, UK; Hoboken, NJ: John Wiley & Sons, 2006.
11. Rith-Najarian S, Branchaud C, Beaulieu O, et al. Reducing lower-extremity amputations due to diabetes. Application of the staged diabetes management approach in a primary care setting. J Fam Pract 1998; 47(2): 127-132. (Pubitemid 28380777)
12. Cypryk K, Cyranowicz B, Jedrzejewska E, et al. The role of staged diabetes management in improving diabetes care in Poland. Pract Diabetes Int 1999; 16(5): 137-141.
13. Mazze RS, Simonson G, Strock E, et al. Staged diabetes management: a systematic evidence-based approach to the prevention and treatment of diabetes and its co-morbidities. Pract Diabetes Int 2001; 18(S7): S1-S16.
14. Leite SAO, Costa PAB, Guse C, et al. Enfoque multidisciplinar ao paciente diabético: avaliação do impacto do "staged diabetes management" em um sistema de saúde privado. Endocrinologia & Metabologia 2001; 45(5): 481-486.
15. Varroud-Vial M, Simon D, Attali J, et al. Improving glycaemic control of patients with type 2 diabetes in a primary care setting: a French application of the Staged Diabetes Management programme. Diabet Med 2004; 21(6): 592-595.
16. Choi SH, Hur KY, Kim DJ, et al. Staged diabetes management according to individual patient insulin resistance and beta-cell function ameliorates glycaemic control in type 2 diabetes mellitus. Clin Endocrinol 2008; 69(4): 549-555.
17. Mohan V, Sandeep S, Deepa R, et al. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007; 125(3): 217-230. (Pubitemid 46805444)
18. 2006 ADA/NCQA Diabetes Physician Recognition Program Standards. www.ncqa.org [accessed 12/2/2008].
19. Nagpal J, Bhartia A. Quality of diabetes care in the middle- and high-income group populace: the Delhi Diabetes Community (DEDICOM) survey. Diabetes Care 2006; 29(11): 2341-2348. (Pubitemid 44912234)
20. de Brito Gomes M, Gianella D, Faria M, et al. Prevalence of type 2 diabetic patients within the targets of care guidelines in daily clinical practice: a multi-center study in Brazil. Rev Diabet Stud 2006; 3(2): 82-87.
21. Aguilar-Salinas CA, Velazquez Monroy O, Gómez-Pérez FJ, et al. Characteristics of patients with type 2 diabetes in Mexico: Results from a large population- based nationwide survey. Diabetes Care 2003; 26(7): 2021-2026.
22. Greenberg HM, Galyavich AS, Ziganshina LE, et al. Identification and management of patients with hypertension in the polyclinic system of the Russian Federation. Am J Hypertens 2005; 18(7): 943-948.
23. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 2006; 144(7): 465-474.
24. Mazze RS, Powers MA, Wetzler HP, et al. Partners in advancing care and education solutions study: impact on processes and outcomes of diabetes care. Popul Health Manag 2008; 11(6): 297-305.
25. Keeter S, Miller C, Kohut A, et al. Consequences of reducing nonresponse in a national telephone survey. Public Opin Q 2000; 64(2):125-148.